The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: An observational study
Số trang: 9
Loại file: pdf
Dung lượng: 1.02 MB
Lượt xem: 7
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Paclitaxel plus S-1(PTXS) has shown definite efcacy for advanced gastric cancer. However, the efcacy and safety of this regimen in neoadjuvant setting for locally advanced gastric cancer (LAGC) are unclear. This study aimed to compare the efcacy of neoadjuvant chemotherapy (NAC) PTXS and oxaliplatin plus S-1 (SOX) regime for patients with LAGC.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Paclitaxel plus S-1 Locally advanced gastric cancer Neoadjuvant chemotherapy Pathological responseGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 169 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 110 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 36 0 0
-
11 trang 35 0 0
-
12 trang 34 0 0